Live Breaking News & Updates on Nasdaq Meip

Stay updated with breaking news from Nasdaq meip. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MEI Pharma (NASDAQ:MEIP) Coverage Initiated at StockNews.com

Analysts at StockNews.com began coverage on shares of MEI Pharma (NASDAQ:MEIP – Get Free Report) in a report issued on Tuesday. The brokerage set a “buy” rating on the stock. Other equities analysts have also issued research reports about the company. TheStreet lowered MEI Pharma from a “c-” rating to a “d+” rating in a […] ....

Stifel Nicolaus , Cable Car Capital , Exchange Commission , Pharma Inc , Get Free Report , Car Capital , Free Report , Mei Pharma , Nasdaq Meip , Initiated Coverage , Stocknews Com ,

MEI Pharma (NASDAQ:MEIP) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Get Free Report) in a note issued to investors on Monday. The firm set a “buy” rating on the stock. A number of other equities analysts have also recently issued reports on MEIP. Stifel Nicolaus reiterated a “hold” rating and issued a $7.00 price target […] ....

Stifel Nicolaus , Cable Car Capital , Pharma Inc , Pharma Company Profile , Get Free Report , Car Capital , Free Report , Mei Pharma , Nasdaq Meip , Initiated Coverage , Stocknews Com ,

MEI Pharma (NASDAQ:MEIP) Price Target Cut to $7.00 by Analysts at Stifel Nicolaus

MEI Pharma (NASDAQ:MEIP – Free Report) had its price objective trimmed by Stifel Nicolaus from $8.00 to $7.00 in a research note issued to investors on Wednesday morning, Benzinga reports. The firm currently has a hold rating on the stock. MEIP has been the topic of a number of other reports. StockNews.com downgraded shares of […] ....

Stifel Nicolaus , National Bank , Pharma Inc , Pharma Company Profile , Northern Trust Corp , Bridgeway Capital Management , Simplex Trading , Free Report , Trust Corp , Capital Management , Get Free Report , Mei Pharma , Nasdaq Meip , Lower Price Target ,

Investment Analysts' Weekly Ratings Changes for MEI Pharma (MEIP)

Several analysts have recently updated their ratings and price targets for MEI Pharma (NASDAQ: MEIP): 2/14/2024 – MEI Pharma had its price target lowered by analysts at Stifel Nicolaus from $8.00 to $7.00. They now have a “hold” rating on the stock. 2/13/2024 – MEI Pharma was downgraded by analysts at StockNews.com from a “buy” […] ....

Stifel Nicolaus , National Bank , Pharma Inc , Simplex Trading , Pharma Inc Daily , Stock Down , Street Group , Inc Daily , Mei Pharma Inc , Nasdaq Meip ,

StockNews.com Begins Coverage on MEI Pharma (NASDAQ:MEIP)

StockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report issued on Sunday morning. The firm issued a hold rating on the stock. Separately, TheStreet raised MEI Pharma from a d- rating to a c- rating in a report on Friday, November 17th. One investment analyst has rated the stock […] ....

Healthcare Of Ontario Pension Plan Trust Fund , Pharma Company Profile , Vanguard Group Inc , Pharma Inc , Renaissance Technologies , Millennium Management , Prudential Financial Inc , Free Report , Get Free Report , Ontario Pension Plan Trust Fund , Vanguard Group , Mei Pharma , Nasdaq Meip , Initiated Coverage , Stocknews Com ,